✦ LIBER ✦

Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study

✍ Scribed by Gregory Sutton; John Blessing; Parviz Hanjani; Paul Kramer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trimetrexate in the Treatment of Recurre

✍ Harriet O. Smith; John A. Blessing; Luis Vaccarello 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Prolonged Oral Etoposide in Recurrent or

✍ Peter G. Rose; John A. Blessing; John T. Soper; James F. Barter 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A phase II evaluation of trabectedin in

✍ Bradley J. Monk; John A. Blessing; Daron G. Street; Carolyn Y. Muller; James J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Ifosfamide and Doxorubicin in the Treatm

✍ Gregory Sutton; John A. Blessing; John H. Malfetano 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase II Trial of Paclitaxel in Leiomyos

✍ Gregory Sutton; John A. Blessing; Harrison Ball 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Phase II Trial of Etoposide in Leiomyosa

✍ Tate Thigpen; John A. Blessing; Edgardo Yordan; Fidel Valea; Luis Vaccarello 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 51 KB